SCHEMBL2812836

SCHEMBL2812836

COc1ccc(O/C=C(C)/C(=N/c2ccc(C)cc2)Sc2ccc(C)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.42
ALDH1A1 P00352 4/20 0.42
HPGD P15428 2/20 0.42
NOS3 P29474 4/20 0.42
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
ACHE P22303 1/20 0.39
RELA Q04206 1/20 0.36
NOS1 P29475 2/20 0.36
NOS2 P35228 2/20 0.36
NPC1 O15118 3/20 0.35
MAPK1 P28482 2/20 0.35
RAB9A P51151 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2812838 1.00 MAPT (0.42) MAPTALDH1A1HPGDNOS3HTR3E
SCHEMBL2811311 0.94 NOS3 (0.39) MAPTALDH1A1HPGDNOS3HTR3E
SCHEMBL2810633 0.94 MAPT (0.40) MAPTALDH1A1HPGDNOS3HTR3E
SCHEMBL2810632 0.94 MAPT (0.40) MAPTALDH1A1HPGDNOS3HTR3E
SCHEMBL2811308 0.94 NOS3 (0.39) MAPTALDH1A1HPGDNOS3HTR3E
SCHEMBL2809905 0.94 NOS3 (0.39) MAPTALDH1A1HPGDNOS3HTR3E
SCHEMBL2809902 0.94 NOS3 (0.39) MAPTALDH1A1HPGDNOS3HTR3E
SCHEMBL2810517 0.88 NOS3 (0.37) MAPTALDH1A1HPGDNOS3HTR3E
SCHEMBL2810516 0.88 NOS3 (0.37) MAPTALDH1A1HPGDNOS3HTR3E
SCHEMBL12850922 0.87 NOS3 (0.42) MAPTALDH1A1HPGDNOS3HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 MAPT 4608/4885ALDH1A1 405/4885HPGD 2145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.